These findings elucidate the molecular mechanism by which MSI2 regulates the PTMs of HMGB1 to reshape the TIME and reprogram immunometabolism, providing new important insights into the role of MSI2 in CRC immunopathology. This evidence concerns the gene MSI2 and colorectal carcinoma.